OverviewSuggest Edit

Cipla is a global pharmaceutical company, which offers active pharmaceutical ingredients and formulations in various therapeutic areas, such as women’s health, cardiovascular, children’s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The Company also provides veterinary products, including anti-infectives, anti-inflammatories, anti-thyroids, immunosuppressants, parasiticides, nutraceuticals, and feed additives for various animals.

TypePublic
Founded1935
HQMumbai, IN
Websitecipla.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Apr 2018)23,043
Share Price (Sept 2020)₹721.6
Cybersecurity ratingFMore

Key People/Management at Cipla

K.a. Hamied

K.a. Hamied

Founder
Umang Vohra

Umang Vohra

Managing Director & Global Chief Executive Officer
Y. K. Hamied

Y. K. Hamied

Non-Executive Chairman
M. K. Hamied

M. K. Hamied

Vice-Chairman
Kedar Upadhye

Kedar Upadhye

Global Chief Financial Officer
Geena Malhotra

Geena Malhotra

Global Head - Integrated Product Development
Show more

Cipla Office Locations

Cipla has offices in Mumbai, Central Islip, South Melbourne, Nairobi and in 7 other locations
Mumbai, IN (HQ)
Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel West, Lower Parel
Mumbai, IN
2nd Floor, Bldg, 5, LBS Rd, Suryanagar No. 2, HMPL Surya Nagar, Vikhroli West
South Melbourne, AU
Level 1/132 Albert Rd
Nairobi, KE
Chiromo Road Purshottam Place
Cape Town, ZA
Mispel Street, Bellville
Durban, ZA
18 The Boulevard, Westway Office Park, Dawncliffe
Show all (13)

Cipla Financials and Metrics

Cipla Revenue

Market capitalization (14-Sept-2020)

603.4b

Closing stock price (14-Sept-2020)

721.6
Cipla's current market capitalization is ₹603.4 b.
Show all financial metrics

Cipla Cybersecurity Score

Cybersecurity ratingPremium dataset

F

44/100

SecurityScorecard logo

Cipla Online and Social Media Presence

Embed Graph

Cipla News and Updates

Deferiprone Market to Eyewitness Massive Growth by 2026 | Apotex & Cipla

Latest launched research document on COVID-19Deferiprone Market study of 90 Pages provides detailed analysis with presentable graphs, charts and tables. Posted via Industry Today. Follow us on Twitter @IndustryToday

Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

MUMBAI, India, Aug. 21, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in...

Cipla e Stempeutics trabalham em parceria para o lançamento do Stempeucel®, a primeira terapia celular 'feita na Índia' para o tratamento da isquemia crítica de membros (ICM)

MUMBAI, Índia, 21 de agosto de 2020 /PRNewswire/ -- A Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), denominada "Cipla", anunciou hoje que sua parceira Stempeutics Research Pvt. Ltd obteve a aprovação regulatória da Controladoria-Geral de Medicamentos da Índia (Drug Controller General of...

ICICI Direct: Cipla Posts Strong Q1 Growth Across India, Europe And Rest Of World

ICICI Direct: Cipla Posts Strong Q1 Growth Across India, Europe And Rest Of World

Stocks To Watch: Affle India, Bata, Cipla, IndusInd Bank, Shree Cement, Titan

Here are the stocks to watch out for in today’s session.

Live: SGX Nifty Indicates A Flat Start; Cipla, Pidilite, M&M, Lupin In Focus

Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.
Show more

Cipla Blogs

Cipla Maroc coverage 1

Morocco inaugurated on Saturday a new metered dose inhalers’ (MDI) production facility in Ain Aouda, near Rabat. – Rabat The factory that represents a 60 MDH investment, is the first of its kind to open in Morocco, according to state-owned media outlet Maghreb Arab Press (MAP). Cipla Morocco, subsid…

Morocco Enhances Pharmaceutical Sector with New Production Facility

Morocco inaugurated on Saturday a new metered dose inhalers’ (MDI) production facility in Ain Aouda, near Rabat. – Rabat The factory that represents a 60 MDH investment, is the first of its kind to open in Morocco, according to state-owned media outlet Maghreb Arab Press (MAP). Cipla Morocco, subsid…

Cipla, Putting Social Stigma to Rest

Abid Hussain Barlaskar , afaqs!, New Delhi In the brand’s latest ad, Priyanka Chopra’s revelation of being an asthmatic is set to dilute the bad buzz around asthma and inhalers. Pharmaceutical company Cipla, in its latest commercial for campaign #BerokZindagi aims at dispelling stigmas around asthma…

Cipla eyes next leg of growth from global biz

In India, the company is by far the leader in the respiratory drugs segment, having a turnover of over Rs 18.93 billion. Sohini Das The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth Cipla, a prominent name in the …

World Post Day

Launched in 1969 by the Universal Postal Congress in Tokyo, JapanWorld Post Day is celebrated each year on 9 October. The purpose of World Post Day is to bring awareness to the post’s role in the everyday lives of people and businesses, as well as its contribution to global social and economic devel…

We are determined to make fearless living a habit: Cipla’s Umang Vohra

Umang Vohra Global CEO, Cipla ‘We are looking to provide end-to-end solutions in the area of disease management for Patients’ Cipla  is looking to make innovation an integral part of its business model. Can you explain what innovation entails for a pharma company? Our innovation philosophy is all ab…
Show more

Cipla Frequently Asked Questions

  • When was Cipla founded?

    Cipla was founded in 1935.

  • Who are Cipla key executives?

    Cipla's key executives are K.a. Hamied, Umang Vohra and Y. K. Hamied.

  • How many employees does Cipla have?

    Cipla has 23,043 employees.

  • Who are Cipla competitors?

    Competitors of Cipla include Pfizer, Par Pharmaceutical and Mylan.

  • Where is Cipla headquarters?

    Cipla headquarters is located at Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel West, Lower Parel, Mumbai.

  • Where are Cipla offices?

    Cipla has offices in Mumbai, Central Islip, South Melbourne, Nairobi and in 7 other locations.

  • How many offices does Cipla have?

    Cipla has 13 offices.